Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis
Stergios A. Pοlyzos(Aristotle University of Thessaloniki), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Eun‐Jung Rhee(Kangbuk Samsung Hospital), Chrysoula Boutari(Aristotle University of Thessaloniki), Eun Seok Kang(Korea University)
Cited by 136
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k